Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: AIDS. 2013 May 15;27(8):10.1097/QAD.0b013e32835e3937. doi: 10.1097/QAD.0b013e32835e3937

Figure 3.

Figure 3

Risk of (A) infant HIV infection and (B) infant HIV infection or death among participants in the intervention group (white) and in the control group (gray), in the primary analysis at 6 weeks, 6 months, and 12 months. Analysis was based on infants active in study at given time point. Among infants born to women with CD4 count > 350 cells/μL at time of regimen initiation (C) infant HIV infection and (D) infant HIV infection or death at 6 weeks, 6 months, and 12 months. P-values denoted above bracket at each time point were calculated based on log-linked binomial regression model adjusted for clustering using generalized estimating equations. 95% CI were calculated using exact binomial methods.